The role of serum PINP in 89Sr pain palliation therapy of prostate cancer patients with bone metastatic disease

被引：0
|
作者：
Siabanopoulou, M. [1 ]
Ordoulidis, S. El Mantani [2 ]
Vasiliadis, T. [1 ]
Dimasis, N. [1 ]
Dikeakou, M. [1 ]
Chantzipavlidou, V. [1 ]
Zaromitidou, E. [3 ]
Haritanti, A. [4 ]
Gotzamani-Psarrakou, A. [4 ]
机构：
[1] Theagenio Canc Inst, Thessaloniki, Greece
[2] Biomed Diagnost, Thessaloniki, Greece
[3] Kavala Gen Hosp, Kavala, Greece
[4] AHEPA Univ Hosp, Thessaloniki, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S245 / S245
页数：1
相关论文
共 50 条
  • [21] PINP as serum marker of metastatic spread to the bone in breast cancer patients
    Lüftner, D
    Jozereau, D
    Schildhauer, S
    Geppert, R
    Müller, C
    Fiolka, G
    Wernecke, KD
    Possinger, K
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1491 - 1499
  • [22] Bone pain palliation with Strontium-89 in cancer patients with bone metastases
    Giammarile, F
    Mognetti, T
    Resche, I
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 2001, 45 (01): : 78 - 83
  • [23] Treatment of Painful Bone Metastases with 89Sr and 186Re-HEDP in Prostate Cancer
    Olmos, R. A. Valdes
    Poel, H. G. Vdr
    Hoefnagel, C. A.
    Sivro, F.
    Baars, P. C.
    Antonini, N.
    Meinhardt, W.
    Weijs, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S199 - S200
  • [24] Prognostic significance of serum angiogenin and Her-2 in 153-Samarium pain palliation therapy of bone metastatic prostate cancer
    Siampanopoulou, M.
    Ordoulidis, S. El-Mantani
    Iakovou, I.
    Dimasis, N.
    Sioundas, A.
    Gotzamani-Psarrakou, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S502 - S503
  • [25] Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review
    van Dodewaard-de Jong, Joyce M.
    Oprea-Lager, Daniela E.
    Hooft, Lotty
    de Klerk, John M. H.
    Bloemendal, Haiko J.
    Verheul, Henk M. W.
    Hoekstra, Otto S.
    van den Eertwegh, Alfons J. M.
    EUROPEAN UROLOGY, 2016, 70 (03) : 416 - 426
  • [26] SR-89 (METASTRON) IN THE TREATMENT OF PROSTATE-CANCER METASTATIC TO BONE
    PORTER, AT
    EUROPEAN UROLOGY, 1994, 26 : 20 - 25
  • [27] Radiophamaceutical bone pain palliation therapy in patients with lung cancer
    Tsaroucha, A.
    Meristoudis, G.
    Liotsou, T.
    Giannakopoulos, V.
    Batsakis, C.
    Balomenos, A.
    Christacopoulou, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S350 - S350
  • [28] Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer:: A randomized clinical trial
    Sciuto, R
    Festa, A
    Rea, S
    Pasqualoni, R
    Bergomi, S
    Petrilli, G
    Maini, CL
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (01) : 79 - 86
  • [29] The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases
    Jan Kasalický
    Věra Krajská
    European Journal of Nuclear Medicine, 1998, 25 : 1362 - 1367
  • [30] Bone turnover parameters ICTP and PINP are promising serum markers for diagnosis and therapy monitoring of bone metastases in prostate cancer patients
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 57 - 57
12345